Permeability Modulation

Permeability Modulation is a bioisosteric strategy that systematically alters the membrane permeability of a pharmacologically active compound by substituting bioisosteres to optimize molecular properties influencing passive diffusion, thereby distinguishing it from other bioisosteric replacements aimed primarily at metabolic stability or target affinity.

69

Publications

3.2K

Citations

355

Authors

111

Institutions

Publications per year

2017–2026

15

Authors

355

  1. BG
    Basile Gallet

    Centre National de la Recherche Scientifique, France

    2 publications · 25 citations

    2

    h-index

  2. YO
    Yoshio Okahata

    Tokyo Institute of Technology, Japan

    2 publications · 120 citations

    2

    h-index

  3. JS
    James S. Scott

    AstraZeneca (United Kingdom), United Kingdom

    2 publications · 37 citations

    2

    h-index

  4. GR
    Graeme R. Robb

    AstraZeneca (United Kingdom), United Kingdom

    2 publications · 37 citations

    2

    h-index

  5. GM
    Gerald Medoff

    Washington University in St. Louis, United States

    2 publications · 73 citations

    2

    h-index

1–5 of 355

Venues

  1. Macromolecules

    3 publications · 175 citations

    3

    h-index

  2. Journal of Medicinal Chemistry

    3 publications · 176 citations

    3

    h-index

  3. Antimicrobial Agents and Chemotherapy

    AAC · 3 publications · 353 citations

    3

    h-index

  4. Bioorganic & Medicinal Chemistry Letters

    3 publications · 50 citations

    3

    h-index

  5. 2

    h-index

1–5